Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Midi Health vs Omnia TeleHealth

Midi Health
Graded #413

Higher grade

vs+0.19999999999999574
Omnia TeleHealth
Graded #418

Lower grade

The verdict

Midi Health takes it — 56.4/100 to 56.2/100, but only just.

Midi Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform. Omnia TeleHealth is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEven
40
40
Clinical oversightOmnia TeleHealth +2
78
80
Labs & monitoringOmnia TeleHealth +9
52
61
FulfillmentMidi Health +16
78
62
Contract termsEven
55
55
Midi Health · left barOmnia TeleHealth · right bar

The numbers

MetricMidi HealthOmnia TeleHealth
WeighScore56.4/10056.2/100
GradeCC
Scorecard rank#413#418
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Midi Health

Graded #413 · C

Strengths

  • Available in all 50 states
  • Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
  • Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
  • Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)

Where it loses points

  • Does not accept Medicare, Medicaid, or Medi-Cal
  • GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
  • Menopause-focused — not the right fit for men or younger women whose main goal is weight loss
Omnia TeleHealth

Graded #418 · C

Strengths

  • LegitScript-certified; DNP-led by Blair Carmichael-Lober with 10+ years clinical experience
  • $69 flat consult fee — no insurance, no surprise bills; works with Belmar Pharma for compounded GLP-1
  • Both semaglutide and tirzepatide available; compounded options via Belmar at lower cost than brand
  • Weight loss visits include nutrition guidance, exercise recommendations, and behavioral coaching
  • Prescriptions sent to any pharmacy nationwide or coordinated through Belmar Pharma Solutions

Where it loses points

  • Only 17 states — specific states not publicly disclosed; must call (251) 220-8875 to confirm
  • Medication pricing is gated — not published on website; contact required for compounded GLP-1 cost
  • No labs mentioned or included — baseline bloodwork protocol not published on any page
  • Medication cost is a separate pharmacy bill; the $69 visit fee covers consult only
  • Smaller platform with limited public track record vs. larger national GLP-1 telehealth providers

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard